Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Maha Atfy"'
Publikováno v:
In Egyptian Journal of Ear, Nose, Throat and Allied Sciences March 2013 14(1):7-10
Autor:
Mervat Azab, Ahmed Mokhtar Ahmed, Maha Atfy, Tamer Hassan, Eman Mohammed Abd El Aziz, Ahmed Mohamed Baraka
Publikováno v:
Zagazig University Medical Journal.
Background: Measurement of minimal residual disease (MRD) reflects the overall response to therapy, and could be used to refine the treatment of acute lymphoblastic leukemia (ALL). MRD studies by flowcytometry rely on panels of antibodies (Abs) to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c476a8b2fd76d5d2fd1b39a7afa4f140
https://doi.org/10.21608/zumj.2021.65960.2162
https://doi.org/10.21608/zumj.2021.65960.2162
Publikováno v:
Egyptian Journal of Ear, Nose, Throat and Allied Sciences. 14(1):7-10
Background In cholesteatoma, there is lack of control over cell proliferation that is why ectodermal tissue grows to be an epidermoid cyst. So cholesteatoma may be considered as cell growth disorder but still the cause of this uncontrolled proliferat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e7fb89c2951da36aa29882cde09176e
Publikováno v:
Medical Oncology. 29:2063-2069
Expression of uPAR (CD87) may play a relevant role in the diagnosis and pathophysiology and prognostic pattern of acute myeloid leukemia. The aims of this study were to find out the prognostic significance of pretreatment detection of CD87 and study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06f8d449bbb3108c6125bb767493d19d
https://doi.org/10.1007/s12032-011-9993-x
https://doi.org/10.1007/s12032-011-9993-x
Publikováno v:
Journal of Clinical Pathology. 64:437-442
Investigation of paraoxonase-1 (PON1) activity with oxidative status parameters and the increased susceptibility to atherogenesis in β-thalassaemia-trait (BTT) subjects.Sixty BTT subjects and 20 age- and sex-matched healthy controls were enrolled in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c15d74ff948b0882a75a904cd0d593c8
https://doi.org/10.1136/jcp.2011.090209
https://doi.org/10.1136/jcp.2011.090209
Autor:
Asmaa Esh, Ebtesam E. Khalil, Maha Atfy, Mohamed M. El Naggar, Layla Sherief, Nashwa M Al Azizi
Publikováno v:
Indian Journal of Hematology and Blood Transfusion. 27:18-25
Impaired apoptosis is mediated by members of the inhibitor of apoptosis proteins (IAP) family such as survivin. Survivin was described in number of different tumors and found to correlate with poor prognosis in a variety of cancers including hematolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0cdae2a96c33704ac18b179783e9a79
https://doi.org/10.1007/s12288-010-0053-z
https://doi.org/10.1007/s12288-010-0053-z
Publikováno v:
Immunological Investigations. 39:820-832
Osteopenia and osteoporosis are considered major health problems in patients suffering from thalassemia due to increased life expectancy of those patients. Osteoprotegerin (OPG) and receptor activator of NF-kappa-B ligand (RANKL) have been recently i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::008f3b9d193ca0461058fba4f290d58c
https://doi.org/10.3109/08820139.2010.498492
https://doi.org/10.3109/08820139.2010.498492
Publikováno v:
Journal of Medical Sciences. 8:28-33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27dd01098eeb5370f442284e372ef90b
https://doi.org/10.3923/jms.2008.28.33
https://doi.org/10.3923/jms.2008.28.33
Publikováno v:
Journal of Leukemia.
Immunosuppression is greatly involved in tumor escape from immune surveillance in acute myeloid leukemia (AML) patients. Being an immunosuppressive molecule, CD200 is upregulated in some hematological malignancies. CD200 also represents an independen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70b8d0fd1d6f19034b8956acfe8e33df
https://doi.org/10.4172/2329-6917.1000190
https://doi.org/10.4172/2329-6917.1000190
Publikováno v:
The Egyptian Journal of Haematology. 42:81
Background Acute lymphoblastic leukemia (ALL) is a biologically heterogeneous disorder. Clinical parameters, immunophenotype, cytogenetic factors, and minimal residual disease (MRD) are among currently used factors in risk stratification and therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43acf1f51f89e72d99b5f42e40bfb680
https://doi.org/10.4103/ejh.ejh_18_17
https://doi.org/10.4103/ejh.ejh_18_17